J B Chemicals & Pharmaceuticals Ltd (JBCHEPHARM) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 461857,
    "name": "J B Chemicals &",
    "stock_name": "J B Chemicals &",
    "full_name": "J B Chemicals & Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/j-b-chemicals-",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,809.05",
    "chg": -14.05,
    "chgp": "-0.77%",
    "dir": -1,
    "prev_price": "1,823.10",
    "mcapval": "28,338.49 Cr",
    "mcap": "Small Cap",
    "scripcode": 506943,
    "symbol": "JBCHEPHARM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE572A01036",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": "7.37 k",
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/j-b-chemicals--461857-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "J B Chemicals & Sees Revised Market Evaluation Amidst Positive Financial Trends",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/j-b-chemicals-upgraded-from-sell-to-hold-by-marketsmojo-on-27-oct-2025-3731057",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/JBChemicals_mojoScore_3731057.png",
        "date": "2025-11-26 09:46:01",
        "description": "J B Chemicals & has experienced a revision in its market evaluation, reflecting changes in its financial and technical outlook. This adjustment highlights evolving perspectives on the company’s quality, valuation, financial trajectory, and technical positioning within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "How has been the historical performance of J B Chemicals &?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-j-b-chemicals-3694446",
        "imagepath": "",
        "date": "2025-11-12 23:39:41",
        "description": "Answer:\nThe historical performance of J B Chemicals & shows a consistent growth trend in net sales and profitability over the years.\n\nBreakdown:\nJ B Chemicals & has demonstrated significant growth in net sales, increasing from 1,643.20 Cr in Mar'19 to 3,917.99 Cr in Mar'25. This upward trajectory reflects a robust annual growth rate, particularly notable from Mar'24 to Mar'25, where sales rose from 3,484.18 Cr to 3,917.99 Cr. The total operating income followed a similar pattern, reaching 3,917.99 Cr in Mar'25. Operating profit, excluding other income, also improved significantly, rising from 305.39 Cr in Mar'19 to 1,031.84 Cr in Mar'25, indicating enhanced operational efficiency. Profit before tax increased from 286.99 Cr in Mar'19 to 887.39 Cr in Mar'25, while profit after tax surged from 193.97 Cr to 659.58 Cr in the same period. The company's total assets grew from 1,813.98 Cr in Mar'20 to 4,265.36 Cr i..."
      },
      {
        "title": "Are J B Chemicals & latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-j-b-chemicals-latest-results-good-or-bad-3693130",
        "imagepath": "",
        "date": "2025-11-12 19:25:41",
        "description": "The latest financial results for J B Chemicals reflect a complex operational landscape. In Q2 FY26, the company reported net sales of ₹1,084.90 crores, which represents an 8.42% year-on-year increase, although there was a marginal sequential decline of 0.83% from the previous quarter. This indicates some near-term revenue challenges, despite the overall healthy year-on-year growth.\n\nNet profit for the same quarter stood at ₹207.82 crores, marking a 19.05% increase compared to the previous year, and a 2.69% rise from the prior quarter. This growth in net profit is attributed to significant margin expansion, with the operating margin improving to 28.54%, up 150 basis points year-on-year. The company has effectively managed its costs, leading to enhanced profitability metrics even amidst fluctuating revenue growth.\n\nThe return on equity (ROE) of 19.49% highlights J B Chemicals' strong capital efficiency, posit..."
      },
      {
        "title": "J B Chemicals Q2 FY26: Margin Expansion Drives 19% Profit Growth Despite Flat Sales",
        "link": "https://www.marketsmojo.com/news/result-analysis/j-b-chemicals-q2-fy26-margin-expansion-drives-19-profit-growth-despite-flat-sales-3690623",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/JBChemicalsPhar_quaterlyResult_3690623.png",
        "date": "2025-11-11 20:02:00",
        "description": "J B Chemicals & Pharmaceuticals Ltd., a Mumbai-based mid-sized pharmaceutical company with a market capitalisation of ₹28,515 crores, delivered a mixed performance in Q2 FY26, reporting net profit of ₹207.82 crores—a modest 2.69% increase quarter-on-quarter but a robust 19.05% surge year-on-year. The company's stock has responded positively to the results, trading at ₹1,826.65 as of November 11, 2025, up 7.62% over the past week and 9.09% over the month, significantly outperforming the broader market."
      },
      {
        "title": "Why is J B Chemicals & falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-j-b-chemicals-fallingrising-3686870",
        "imagepath": "",
        "date": "2025-11-10 21:42:21",
        "description": "As of 10-Nov, J B Chemicals & Pharmaceuticals Ltd is experiencing a price increase, with the current price at 1,813.40, reflecting a rise of 111.75 or 6.57%. The stock has shown strong performance today, outperforming its sector by 5.52% and achieving a consecutive gain over the last two days, with a total return of 7.16% during this period. Additionally, the stock has touched an intraday high of Rs 1820, indicating positive momentum. Over the past week, the stock has risen by 5.80%, while its one-month return stands at 8.30%. The company benefits from high management efficiency, evidenced by a return on equity (ROE) of 19.49%, and a low debt-to-equity ratio of 0.02 times. Furthermore, institutional holdings have increased by 0.73% over the previous quarter, suggesting confidence from larger investors.\n\nIn the broader market context, while J B Chemicals has outperformed the Sensex, which has declined by 0.5..."
      },
      {
        "title": "Is J B Chemicals & technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-j-b-chemicals-technically-bullish-or-bearish-3683979",
        "imagepath": "",
        "date": "2025-11-10 08:10:17",
        "description": "As of 7 November 2025, the technical trend for J B Chemicals & has changed from sideways to mildly bullish. The daily moving averages indicate a bullish stance, while the weekly and monthly MACD and KST readings are mildly bearish, suggesting some caution. The RSI shows no signals in both weekly and monthly time frames, and Bollinger Bands are sideways, indicating a lack of volatility. Overall, the current technical stance is mildly bullish, driven primarily by the daily moving averages, despite the bearish signals from other indicators...."
      },
      {
        "title": "J B Chemicals & Pharmaceuticals Shows Mixed Technical Trends Amid Market Evaluation Revision",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/j-b-chemicals-pharmaceuticals-technical-trend-shifts-from-sideways-to-mildly-bullish-amid-stock-price-increase-3684395",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/JBChemicalsPhar_technicaldot_3684395.png",
        "date": "2025-11-10 08:02:19",
        "description": "J B Chemicals & Pharmaceuticals has recently revised its evaluation amid current market dynamics. The stock, priced at 1,700.00, has seen an 8.62% decline over the past year, contrasting with the Sensex's gain. Notably, the company has achieved significant long-term returns, outperforming the Sensex over five and three years."
      },
      {
        "title": "Is J B Chemicals & technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-j-b-chemicals-technically-bullish-or-bearish-3682844",
        "imagepath": "",
        "date": "2025-11-09 08:10:38",
        "description": "As of 7 November 2025, the technical trend for J B Chemicals & has changed from sideways to mildly bullish. The daily moving averages indicate a bullish stance, while the weekly and monthly MACD and KST are mildly bearish, suggesting mixed signals across different time frames. The RSI shows no signal on both weekly and monthly charts, and Bollinger Bands are sideways, indicating a lack of volatility. Overall, the current technical stance is mildly bullish, primarily driven by the daily moving averages, despite the bearish signals from longer-term indicators...."
      },
      {
        "title": "Is J B Chemicals & technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-j-b-chemicals-technically-bullish-or-bearish-3682072",
        "imagepath": "",
        "date": "2025-11-08 08:14:10",
        "description": "As of 7 November 2025, the technical trend for J B Chemicals & has changed from sideways to mildly bullish. The daily moving averages indicate a bullish stance, while the weekly and monthly MACD and KST readings are mildly bearish. The RSI shows no signal in both weekly and monthly time frames, and Bollinger Bands are sideways. Overall, the current technical stance is mildly bullish, driven primarily by the bullish daily moving averages despite the bearish signals from the MACD and KST on longer time frames...."
      }
    ],
    "total": 365,
    "sid": "461857",
    "stock_news_url": "https://www.marketsmojo.com/news/j-b-chemicals-pharmaceuticals-461857"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
      "datetime": "23-Nov-2025",
      "details": "Allotment of Equity Shares on exercise of stock options pursuant to Employee Stock Option Scheme",
      "source": "BSE"
    },
    {
      "caption": "Updates on Open Offer",
      "datetime": "17-Nov-2025",
      "details": "NovaaOne Capital Pvt Ltd (Manager to the Open Offer) has submitted to BSE a copy of Offer Opening Advertisement under Regulations 18(7) of Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations 2011 as amended (SEBI (SAST) Regulations) and Corrigendum to the Detailed Public Statement for the attention of the eligible Shareholders of JB Chemicals & Pharmaceuticals Ltd (Target Company).",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
      "datetime": "14-Nov-2025",
      "details": "Transcript of Investors/Analysts call",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "J B Chemicals & Pharmaceuticals Ltd has declared <strong>700%</strong> dividend, ex-date: 30 Jul 25",
          "dt": "2025-07-30",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "J B Chemicals & Pharmaceuticals Ltd has announced <strong>1:2</strong> stock split, ex-date: 18 Sep 23",
          "dt": "2023-09-18",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

J B Chemicals & Sees Revised Market Evaluation Amidst Positive Financial Trends

2025-11-26 09:46:01

J B Chemicals & has experienced a revision in its market evaluation, reflecting changes in its financial and technical outlook. This adjustment highlights evolving perspectives on the company’s quality, valuation, financial trajectory, and technical positioning within the Pharmaceuticals & Biotechnology sector.

How has been the historical performance of J B Chemicals &?

2025-11-12 23:39:41

Answer: The historical performance of J B Chemicals & shows a consistent growth trend in net sales and profitability over the years. Breakdown: J B Chemicals & has demonstrated significant growth in net sales, increasing from 1,643.20 Cr in Mar'19 to 3,917.99 Cr in Mar'25. This upward trajectory reflects a robust annual growth rate, particularly notable from Mar'24 to Mar'25, where sales rose from 3,484.18 Cr to 3,917.99 Cr. The total operating income followed a similar pattern, reaching 3,917.99 Cr in Mar'25. Operating profit, excluding other income, also improved significantly, rising from 305.39 Cr in Mar'19 to 1,031.84 Cr in Mar'25, indicating enhanced operational efficiency. Profit before tax increased from 286.99 Cr in Mar'19 to 887.39 Cr in Mar'25, while profit after tax surged from 193.97 Cr to 659.58 Cr in the same period. The company's total assets grew from 1,813.98 Cr in Mar'20 to 4,265.36 Cr i...

Are J B Chemicals & latest results good or bad?

2025-11-12 19:25:41

The latest financial results for J B Chemicals reflect a complex operational landscape. In Q2 FY26, the company reported net sales of ₹1,084.90 crores, which represents an 8.42% year-on-year increase, although there was a marginal sequential decline of 0.83% from the previous quarter. This indicates some near-term revenue challenges, despite the overall healthy year-on-year growth. Net profit for the same quarter stood at ₹207.82 crores, marking a 19.05% increase compared to the previous year, and a 2.69% rise from the prior quarter. This growth in net profit is attributed to significant margin expansion, with the operating margin improving to 28.54%, up 150 basis points year-on-year. The company has effectively managed its costs, leading to enhanced profitability metrics even amidst fluctuating revenue growth. The return on equity (ROE) of 19.49% highlights J B Chemicals' strong capital efficiency, posit...

J B Chemicals Q2 FY26: Margin Expansion Drives 19% Profit Growth Despite Flat Sales

2025-11-11 20:02:00

J B Chemicals & Pharmaceuticals Ltd., a Mumbai-based mid-sized pharmaceutical company with a market capitalisation of ₹28,515 crores, delivered a mixed performance in Q2 FY26, reporting net profit of ₹207.82 crores—a modest 2.69% increase quarter-on-quarter but a robust 19.05% surge year-on-year. The company's stock has responded positively to the results, trading at ₹1,826.65 as of November 11, 2025, up 7.62% over the past week and 9.09% over the month, significantly outperforming the broader market.

Why is J B Chemicals & falling/rising?

2025-11-10 21:42:21

As of 10-Nov, J B Chemicals & Pharmaceuticals Ltd is experiencing a price increase, with the current price at 1,813.40, reflecting a rise of 111.75 or 6.57%. The stock has shown strong performance today, outperforming its sector by 5.52% and achieving a consecutive gain over the last two days, with a total return of 7.16% during this period. Additionally, the stock has touched an intraday high of Rs 1820, indicating positive momentum. Over the past week, the stock has risen by 5.80%, while its one-month return stands at 8.30%. The company benefits from high management efficiency, evidenced by a return on equity (ROE) of 19.49%, and a low debt-to-equity ratio of 0.02 times. Furthermore, institutional holdings have increased by 0.73% over the previous quarter, suggesting confidence from larger investors. In the broader market context, while J B Chemicals has outperformed the Sensex, which has declined by 0.5...

Is J B Chemicals & technically bullish or bearish?

2025-11-10 08:10:17

As of 7 November 2025, the technical trend for J B Chemicals & has changed from sideways to mildly bullish. The daily moving averages indicate a bullish stance, while the weekly and monthly MACD and KST readings are mildly bearish, suggesting some caution. The RSI shows no signals in both weekly and monthly time frames, and Bollinger Bands are sideways, indicating a lack of volatility. Overall, the current technical stance is mildly bullish, driven primarily by the daily moving averages, despite the bearish signals from other indicators....

J B Chemicals & Pharmaceuticals Shows Mixed Technical Trends Amid Market Evaluation Revision

2025-11-10 08:02:19

J B Chemicals & Pharmaceuticals has recently revised its evaluation amid current market dynamics. The stock, priced at 1,700.00, has seen an 8.62% decline over the past year, contrasting with the Sensex's gain. Notably, the company has achieved significant long-term returns, outperforming the Sensex over five and three years.

Is J B Chemicals & technically bullish or bearish?

2025-11-09 08:10:38

As of 7 November 2025, the technical trend for J B Chemicals & has changed from sideways to mildly bullish. The daily moving averages indicate a bullish stance, while the weekly and monthly MACD and KST are mildly bearish, suggesting mixed signals across different time frames. The RSI shows no signal on both weekly and monthly charts, and Bollinger Bands are sideways, indicating a lack of volatility. Overall, the current technical stance is mildly bullish, primarily driven by the daily moving averages, despite the bearish signals from longer-term indicators....

Is J B Chemicals & technically bullish or bearish?

2025-11-08 08:14:10

As of 7 November 2025, the technical trend for J B Chemicals & has changed from sideways to mildly bullish. The daily moving averages indicate a bullish stance, while the weekly and monthly MACD and KST readings are mildly bearish. The RSI shows no signal in both weekly and monthly time frames, and Bollinger Bands are sideways. Overall, the current technical stance is mildly bullish, driven primarily by the bullish daily moving averages despite the bearish signals from the MACD and KST on longer time frames....

View All News